| 1 |
Arora P, Vasa P, Brenner D, et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey [J]. CMAJ,2013, 185(9): E417-E423.
|
| 2 |
Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States [J]. JAMA, 2007, 298(17): 2038-2047.
|
| 3 |
Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review [J]. BMC Public Health, 2008, 8: 117.
|
| 4 |
Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey [J]. Lancet, 2012, 379(9818): 815-822.
|
| 5 |
O'Hare AM, Bertenthal D, Covinsky KE, et al. Mortality risk stratification in chronic kidney disease: one size for all ages [J]? J Am Soc Nephrol, 2006, 17(3): 846-853.
|
| 6 |
Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes [J]. JAMA,2010, 303(5): 423-429.
|
| 7 |
Bloch MJ, Basile J. What should be the target blood pressure in patients with chronic kidney disease? Data from the Kidney Early Evaluation Program [J]. J Clin Hypertens (Greenwich), 2012, 14(7): 472-474.
|
| 8 |
Sarafidis PA, Li S, Chen SC, et al. Hypertension awareness,treatment, and control in chronic kidney disease [J]. Am J Med,2008, 121(4): 332-340.
|
| 9 |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease [J]. Kidney Int, 2013,Suppl 3(1): 1-150.
|
| 10 |
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [J]. J Hypertens, 2013, 31(7): 1281-1357.
|
| 11 |
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) [J]. JAMA, 2014, 311(5): 507-520.
|
| 12 |
Franklin SS, Gustin Wt, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study[J]. Circulation, 1997, 96(1): 308-315.
|
| 13 |
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) [J]. JAMA, 1991, 265(24): 3255-3264.
|
| 14 |
Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials [J]. Lancet, 2000, 355(9207): 865-872.
|
| 15 |
Zanchetti A. Target blood pressure in elderly hypertensive patients:how low should you go [J]? Blood Press Suppl, 2000, 2: 7-11.
|
| 16 |
Schafer HH, Sudano I, Theus GR, et al. Blood pressure target attainment in the background of guidelines: the very elderly in Swiss primary care [J]. Fam Pract, 2012, 29(5): 511-520.
|
| 17 |
Ogihara T, Nakao K, Fukui T, et al. The optimal target blood pressure for antihypertensive treatment in Japanese elderly patients with high-risk hypertension: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial [J].Hypertens Res, 2008, 31(8): 1595-1601.
|
| 18 |
Aronow WS. Data are needed on target blood pressure for elderly people [J]. J Am Geriatr Soc, 2009, 57(11): 2177, author reply 2177-2178.
|
| 19 |
Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older [J]. New Engl J Med, 2008, 358(18): 1887-1898.
|
| 20 |
Ogihara T, Saruta T, Rakugi H, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study [J]. Hypertension,2010, 56(2): 196-202.
|
| 21 |
Group JS. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)[J]. Hypertens Res, 2008, 31(12): 2115-2127.
|
| 22 |
Rakugi H, Ogihara T, Goto Y, et al. Comparison of strict- and mildblood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOS [J]. Hypertens Res, 2010, 33(11): 1124-1128.
|
| 23 |
Terawaki H, Metoki H, Nakayama M, et al. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study [J]. Hypertens Res, 2008, 31(12): 2129-2135.
|
| 24 |
Cai G, Zheng Y, Sun X, et al. Prevalence, awareness, treatment,and control of hypertension in elderly adults with chronic kidney disease: results from the survey of Prevalence, Awareness, and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China [J]. J Am Geriatr Soc, 2013, 61(12): 2160-2167.
|
| 25 |
Denker MG, Cohen DL. What is an appropriate blood pressure goal for the elderly:review of recent studies and practical recommendations [J]. Clin Interv Aging, 2013, 8: 1505-1517.
|